CAS RN: 112251-56-6
N-[2-[5-(DIMETHYLAMINOMETHYL)-2-FURFURYLTHIO]ETHYL]-2-NITRO-ACETAMIDE SODIUM SALT
Product Availability
Choose a grade to view its available package options.
5 package records5 with current stock1 grade group
| Batch No. | Package | Availability | Inquiry |
| Batchno.20260322 |
100mg |
In stock |
Inquiry |
| Batchno.20250424 |
10mg |
In stock |
Inquiry |
| Batchno.20250312 |
1mg |
In stock |
Inquiry |
| Batchno.20250514 |
50mg |
In stock |
Inquiry |
| Batchno.20251021 |
5mg |
In stock |
Inquiry |
-
Product code:
starshine_CAS112251-56-6
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
112251-56-6 / sodium (Z)-1-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethylamino]-2-nitroethenolate
Demethylamino Ranitidine Acetamide Sodium | N-[2-[5-(DIMETHYLAMINOMETHYL)-2-FURFURYLTHIO]ETHYL]-2-NITRO-ACETAMIDE SODIUM SALT | sodium;(Z)-1-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethylamino]-2-nitroethenolate
Standard CAS: 112251-56-6
Multi CAS: Yes
Basic Information
CAS
112251-56-6
Multi CAS
Yes
Molecular Formula
C12H18N3NaO4S
Molecular Weight
323.350000
Exact Mass
323.091572
SMILES
CN(C)CC1=CC=C(O1)CSCCN/C(=C/[N+](=O)[O-])/[O-].[Na+]
InChI
InChI=1S/C12H19N3O4S.Na/c1-14(2)7-10-3-4-11(19-10)9-20-6-5-13-12(16)8-15(17)18;/h3-4,8,13,16H,5-7,9H2,1-2H3;/q;+1/p-1/b12-8-;
InChIKey
YWETXBRGXAEYGG-JCTPKUEWSA-M
Synonyms
Demethylamino Ranitidine Acetamide Sodium
N-[2-[5-(DIMETHYLAMINOMETHYL)-2-FURFURYLTHIO]ETHYL]-2-NITRO-ACETAMIDE SODIUM SALT
sodium;(Z)-1-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethylamino]-2-nitroethenolate
MFCD08275602
DTXSID50551855
Computed Properties
Structural Parameters
Heavy atom count
21
Aromatic heavy atom count
5
Fraction Csp3
0.5
Rotatable bonds
9
H-bond acceptors
7
H-bond donors
1
Molar refractivity
75.34
TPSA
94.61
LogP / Solubility
WLOGP
-2.4
MLOGP
-2.09
XLogP3
-2.4
Consensus LogP
-2.3
Log S (ESOL)
0.08
Class (ESOL)
Highly soluble
Log S (Ali)
-0.48
Class (Ali)
Very soluble
Log S (SILICOS-IT)
-0.85
Class (SILICOS-IT)
Very soluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-6.39
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2.5
Safety & Transport
Pictogram(s)
Irritant
Signal
Warning
GHS Hazard Statements
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
Precautionary Statement Codes
P264, P270, P301+P317, P330, and P501